Full-Time
Veterans Affairs Strategic Partnership Lead
Confirmed live in the last 24 hours
Rune Labs
51-200 employees
Develops software for neuromodulation applications
Compensation Overview
$130k - $175kAnnually
Senior, Expert
No H1B Sponsorship
Washington, DC, USA
Preferred location is Washington DC area; will consider other locations near major PADRECCs for exceptional candidates.
You match the following Rune Labs's candidate preferences
Employers are more likely to interview you if you match these preferences:
- 7+ years of experience working with VA healthcare system
- Deep understanding of VA procurement processes and purchasing vehicles
- Experience implementing healthcare technology solutions within VA
- Track record of successfully engaging VA clinical stakeholders
- Strong project management and analytical skills
- Bachelor's degree required; relevant healthcare/business advanced degree preferred
- Possess current U.S. work authorization
- Develop and execute VA market access strategy, including navigation of VA procurement processes and frameworks
- Structure and negotiate contracts through appropriate VA purchasing vehicles
- Ensure compliance with VA IT security requirements and data handling standards
- Navigate VA's connected health product approval process
- Coordinate with VA's Office of Connected Care and relevant innovation offices
- Build relationships with leadership and clinicians across all six PADRECCs
- Engage with the 51 Consortium Centers that provide regional Parkinson's care
- Support VA-specific clinical evidence generation and outcomes tracking
- Facilitate integration of StrivePD into VA clinical workflows
- Partner with veteran service organizations focused on Parkinson's disease
- Develop relationships with veteran advocacy groups
- Create veteran-specific educational and support materials
- Ensure product accessibility for veteran population
- Design implementation strategy that aligns with VA's clinical care pathway for Parkinson's
- Develop programs to support rural veterans through VA telehealth integration
- Create training programs for VA clinical staff
- Build metrics and reporting frameworks aligned with VA requirements
- Background working with PADRECCs or VA neurology services
- Experience with VA connected health initiatives
- Knowledge of VA telehealth programs
- Understanding of veteran-specific healthcare needs
- Experience with federal IT security requirements
- Background in patient engagement programs
Rune Labs develops software solutions for neuromodulation applications aimed at treating chronic neurological diseases like Parkinson's, epilepsy, and Alzheimer's. Their software is designed to work with brain-machine interfaces, which help restore mobility to paralyzed patients, accelerate stroke recovery, and may enhance cognitive functions and mood control. Unlike many competitors, Rune Labs focuses specifically on the intersection of neuroscience and healthcare, catering to medical researchers, healthcare providers, and patients. The company's goal is to advance the capabilities of neuromodulation devices through their specialized software, which they develop and license for revenue.
Company Size
51-200
Company Stage
Seed
Total Funding
$40.1M
Headquarters
San Francisco, null
Founded
2018
Simplify's Take
What believers are saying
- Increased adoption of wearable tech boosts demand for Rune Labs' StrivePD platform.
- Rise of personalized medicine allows Rune Labs to tailor therapies to individual needs.
- Growing interest in remote monitoring benefits Rune Labs' real-time data collection solutions.
What critics are saying
- Competition from Kernel and Neuralink may impact Rune Labs' market share.
- Rapid AI advancements could outpace Rune Labs' current technological capabilities.
- Regulatory challenges may delay product approvals for neuromodulation devices.
What makes Rune Labs unique
- Rune Labs integrates with Apple Watch for real-time Parkinson's symptom tracking.
- The company offers a cloud-based platform for scalable neuromodulation therapy management.
- Rune Labs' StriveStudy platform enables efficient, real-world data collection for clinical trials.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Remote Work Options
401(k) Company Match
Performance Bonus
Equity eligible
Growth & Insights and Company News
6 month growth
↑ 3%1 year growth
↑ 0%2 year growth
↑ 3%Rune Labs launches GenAI clinical support to accelerate care management for Parkinson's patients and clinicians.
Rune Labs, a precision neurology software and data company, today announced a strategic round of $12 million, increasing the total amount raised by th
Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson's disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.
Jordi Parramon, PhD, CEO, General Partner and Co-Founder of Nexus NeuroTech Ventures and former President of Medical Devices at Verily, will join Rune Labs' board of directors.
Rune Labs launches StriveStudy clinical development platform to streamline enrollment, enable real world evidence (RWE) generation, monitor patient compliance with a study, and improve patient study experienceCell therapy developer BlueRock is first to deploy StriveStudy, in conjunction with Rune Labs' StrivePD platform, to remotely collect real-time patient data and monitor patient compliance in research studySAN FRANCISCO, March 14, 2023 /PRNewswire/ -- Rune Labs , a precision neurology software and data platform company, today announced a partnership with BlueRock Therapeutics , a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG. BlueRock will use StriveStudy, Rune Labs' clinical trial platform featuring data collection and patient monitoring tools, to capture a holistic and precise picture of Parkinson's disease activity and to better engage patients in the study.The partnership is the first deployment of Rune Labs' StriveStudy clinical trial platform, which enables more efficient studies of disease-modifying therapeutics to treat movement disorders. BlueRock will leverage Rune Labs' Apple Watch-enabled data collection and remote patient monitoring tools in a non-interventional study, providing real-world, continuous capture of Parkinson's symptom data using Rune Labs' 510(k)-cleared technology.Rune Labs' StriveStudy platform will capture multimodal data from people with Parkinson's to gain a better understanding of individual disease experience and build a dataset to characterize baseline symptom activity. BlueRock can leverage StriveStudy to monitor patient compliance by tracking how often they wear the Apple Watch in the study, as well as to improve the study experience for patients by streamlining data collection."Parkinson's disease research has been limited in the past because there is no easy-to-measure, singular set of symptoms that each patient experiences – people with Parkinson's have a wide array of symptoms that vary from person to person and frequently fluctuate. Historically, clinical researchers have used patient-reported questionnaires to assess symptoms, but they're a subjective tool that fails to capture the dynamic nature of the disease," said Rune Labs CEO Brian Pepin. "Together, BlueRock and Rune Labs will remotely collect longitudinal and objective data directly from patients to create a comprehensive image of Parkinson's symptoms